InsidersTradesSigma
NU Skin Enterprises, INC. Stock: price and insider trades · United States · SEC (Form 4)
Track the NU Skin Enterprises, INC. share price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, NU Skin Enterprises, INC. has logged 206 reports. Market capitalisation: €251m. The latest transaction was disclosed on 3 June 2026 (Attribution). Among the most active insiders: LIPMAN ANDREW D. Every trade is free.
206
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€6m
47 ops.
Sell Volume
37Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 717 of 26,063 companies
82.4
score / 100
Value97
Quality68
FCF yld18%
Earn yld64%
EV/EBITDA2.1x
ROE7.0%
Gross mgn69%
Net mgn11%
Debt/EBITDA1.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 3 June 2026
Declarations206 total
26,643 shares0Class A Common StockSEC:0001021561-26-000057:0
26,643 shares0Class A Common StockSEC:0001021561-26-000055:0
27 shares@ US$13.130.8% of flowClass A Common StockSEC:0001062993-25-006151:0
12 shares@ US$8.160.1% of flowClass A Common StockSEC:0001062993-25-004821:0
51,747 shares0Class A Common StockSEC:0001062993-25-003804:0
64,684 shares0Class A Common StockSEC:0001062993-25-003802:0
71,152 shares0Class A Common StockSEC:0001062993-25-003793:0
310,479 shares0Class A Common StockSEC:0001062993-25-003788:0
113,196 shares0Class A Common StockSEC:0001062993-25-003797:0
1,693 shares@ US$7.7315.2% of flowClass A Common StockSEC:0001062993-25-003364:0
10,856 shares@ US$7.569.9% of flowClass A Common StockSEC:0001062993-25-002884:0
40,857 shares@ US$7.5610.0% of flowClass A Common StockSEC:0001062993-25-002882:0
5,552 shares@ US$7.5699.2% of flowClass A Common StockSEC:0001062993-25-002892:0
14,227 shares@ US$7.5618.0% of flowClass A Common StockSEC:0001062993-25-002886:0
8,949 shares@ US$7.565.8% of flowClass A Common StockSEC:0001062993-25-002888:0
17,694 shares0Class A Common StockSEC:0001062993-25-002532:0
3,686 shares0Class A Common StockSEC:0001062993-25-002554:0
6,451 shares0Class A Common StockSEC:0001062993-25-002548:0
4,055 shares0Class A Common StockSEC:0001062993-25-002540:0
1,198 shares0Class A Common StockSEC:0001062993-25-002559:0
9,070 shares@ US$6.6010.1% of flowClass A Common StockSEC:0001062993-24-021202:0
13 shares@ US$7.460.1% of flowClass A Common StockSEC:0001062993-24-020556:0
15,935 shares0Class A Common StockSEC:0001062993-24-016531:0
14 shares@ US$7.620.1% of flowClass A Common StockSEC:0001062993-24-016533:0
1,638 shares@ US$10.952.1% of flowClass A Common StockSEC:0001062993-24-014453:0
25 of 206 declarations
About NU Skin Enterprises, INC.
Nu Skin Enterprises, Inc. (NYSE: NUS) is a U.S.-listed company on the New York Stock Exchange, headquartered in Provo, Utah, United States. Founded in 1984, the company grew out of a direct-selling model and has evolved into a global beauty and wellness platform that combines consumer brands, product innovation, and an affiliate-based distribution network. For investors, Nu Skin should be viewed as a specialized consumer-health and prestige-beauty franchise with exposure to anti-aging, preventive wellness, and social/digital commerce trends. ([nuskin.com](https://www.nuskin.com/in/en/site/company/about-us?utm_source=openai))\n\nThe business is organized around two principal product categories: beauty and wellness. Under the Nu Skin brand, the company sells skincare, personal care, and beauty device systems. Under Pharmanex, it offers nutritional supplements and wellness-oriented products. The ageLOC franchise is a core differentiator, spanning anti-aging skincare, connected beauty devices, and products positioned around healthy aging. Nu Skin emphasizes more than 40 years of scientific research, clinical substantiation, and innovation as part of its premium brand positioning and distributor appeal. ([ir.nuskin.com](https://ir.nuskin.com/news-releases/news-release-details/nu-skin-enterprises-announce-fourth-quarter-and-full-year-2025?utm_source=openai))\n\nNu Skin operates in nearly 50 markets worldwide, giving it a broad geographic footprint across Asia-Pacific, the Americas, Europe, and other international regions. That global reach supports revenue diversification and brand visibility, but it also introduces foreign-exchange volatility, local regulatory complexity, and uneven consumer demand across regions. In 2025, revenue was primarily generated by the beauty and wellness categories, while the Rhyz ecosystem contributed additional income through adjacent consumer, technology, and manufacturing activities. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1021561/000114036126013156/ef20069502_ars.pdf?utm_source=openai))\n\nFrom a competitive standpoint, Nu Skin operates in a crowded landscape that includes multinational cosmetics groups, direct-selling peers, and digitally native consumer brands. Its competitive advantages lie in its long operating history, international affiliate base, premium product portfolio, and recurring product-launch cadence. Recent company disclosures show that fiscal 2025 results came in within guidance, and the company’s initial fiscal 2026 outlook points to a return to revenue growth by year-end. Recent notable initiatives include the launch of Prysm iO and continued expansion of ageLOC lines, signaling an ongoing effort to reignite organic growth and strengthen customer and affiliate retention. ([ir.nuskin.com](https://ir.nuskin.com/news-releases/news-release-details/nu-skin-enterprises-reports-fourth-quarter-and-full-year-2025?utm_source=openai))
